Intech Biopharm Corporation announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was TWD 4.290 million compared to TWD 4.204 million a year ago. Operating loss was TWD 67.462 million compared to TWD 54.686 million a year ago. Net loss was TWD 68.729 million compared to TWD 50.594 million a year ago. Basic loss per share was TWD 0.86 compared to TWD 0.72 a year ago.